Literature DB >> 28507401

Economic evaluation of medicines.

Colman Taylor1, Stephen Jan2.   

Abstract

Keywords:  Pharmaceutical Benefits Scheme; cost of drugs; health economics

Year:  2017        PMID： 28507401      PMCID： PMC5407996          DOI： 10.18773/austprescr.2017.014

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  1 in total

1.  Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in australia (1991 to 1996).

Authors:  B George; A Harris; A Mitchell
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981
  1 in total
  9 in total

1.  Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature.

Authors:  C-H Wu; I-J Kao; W-C Hung; S-C Lin; H-C Liu; M-H Hsieh; S Bagga; M Achra; T-T Cheng; R-S Yang
Journal:  Osteoporos Int       Date:  2018-02-19       Impact factor: 4.507

2.  A gender-sensitised weight-loss and healthy living program for men with overweight and obesity in Australian Football League settings (Aussie-FIT): A pilot randomised controlled trial.

Authors:  Dominika Kwasnicka; Nikos Ntoumanis; Kate Hunt; Cindy M Gray; Robert U Newton; Daniel F Gucciardi; Cecilie Thøgersen-Ntoumani; Jenny L Olson; Joanne McVeigh; Deborah A Kerr; Sally Wyke; Philip J Morgan; Suzanne Robinson; Marshall Makate; Eleanor Quested
Journal:  PLoS Med       Date:  2020-08-06       Impact factor: 11.069

3.  Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancer.

Authors:  Noga Gershon; Yakir Berchenko; Peter S Hall; Daniel A Goldstein
Journal:  Cost Eff Resour Alloc       Date:  2019-02-28

4.  The Cost-Effectiveness of Supplemental Carnosine in Type 2 Diabetes.

Authors:  Kirthi Menon; Barbora de Courten; Dianna J Magliano; Zanfina Ademi; Danny Liew; Ella Zomer
Journal:  Nutrients       Date:  2022-01-04       Impact factor: 6.706

Review 5.  Health Economic Aspects of Childhood Excess Weight: A Structured Review.

Authors:  Olu Onyimadu; Mara Violato; Nerys M Astbury; Susan A Jebb; Stavros Petrou
Journal:  Children (Basel)       Date:  2022-03-24

6.  The cost-effectiveness of digital health interventions: A systematic review of the literature.

Authors:  Andrea Gentili; Giovanna Failla; Andriy Melnyk; Valeria Puleo; Gian Luca Di Tanna; Walter Ricciardi; Fidelia Cascini
Journal:  Front Public Health       Date:  2022-08-11

7.  5-Aminolevulinic Acid Hydrochloride (5-ALA)-Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2020-03-06

8.  The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson's disease.

Authors:  Jesper Jørgensen; Spiros Servos; Panos Kefalas
Journal:  J Mark Access Health Policy       Date:  2018-08-06

Review 9.  Tumour treating fields therapy for glioblastoma: current advances and future directions.

Authors:  Ola Rominiyi; Aurelie Vanderlinden; Susan Jane Clenton; Caroline Bridgewater; Yahia Al-Tamimi; Spencer James Collis
Journal:  Br J Cancer       Date:  2020-11-04       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.